The differences in gene expression and alternative splicing (AS) patterns between the RPL8-OE and control (Ctrl) samples were analyzed to determine whether the dysregulated genes are enriched in tumorigenesis-related pathways and to investigate the pathways through which RPL8 participates in tumor progression. The gene discussed is RPL8; the disease is neoplasm.